As this report illustrates, the complex process of diagnosing mesothelioma is constantly evolving.
Raleigh, NC (PRWEB) August 07, 2015
University of Chicago researchers say they scoured the medical literature and other pathologists to compile a list of the most reliable methods for diagnosing mesothelioma, an aggressive cancer linked to asbestos. Surviving Mesothelioma has just published an article on their findings. Click here to read it now.
In their new report, a pair of doctors in the UC Department of Pathology name four key proteins and a tumor suppressing molecule they say are showing promise in the difficult process of mesothelioma diagnosis.
“It is important to correlate histologic findings on adequate biopsy samples with clinical and radiologic features,” write Dr. Qudsia Arif and Dr. Aliya Husain.
The report in the Archives of Pathology and Laboratory Medicine notes that the tumor suppressor p16 is missing in 70 percent of epithelioid mesotheliomas and could offer another way to help diagnose the disease.
“As this report illustrates, the complex process of diagnosing mesothelioma is constantly evolving,” says Alex Strauss, Managing Editor of Surviving Mesothelioma. “We are committed to helping patients and their families stay on top of those changes with the newest and most reliable medical information.”
For more details of the new report, see A New Look at the Complex Process of Mesothelioma Diagnosis, now available on the Surviving Mesothelioma website.
Arif, Q and Husain, AN, “Malignant Mesothelioma Diagnosis,” Archives of Pathology and Laboratory Medicine, August 2015, pp. 978-980. http://www.ncbi.nlm.nih.gov/pubmed/26230591
For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.